Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

New TYK2 inhibitors designed at Cellzome

June 11, 2012

Beta Pharma synthesizes new glucokinase activators

June 11, 2012

New thrombin inhibitors generated by Chinese team

June 11, 2012

Canadian company discloses novel calcium channel blockers

June 11, 2012

Scientists at Callidus Biopharma patent new proteins for lysosomal storage disorders

June 11, 2012

New fatty acid synthase inhibitors patented by GlaxoSmithKline

June 11, 2012

Nektar Therapeutics designs novel polymer-G-CSF conjugates

June 11, 2012

Medivir and Janssen team up to develop new agents for hepatitis

June 11, 2012

Researchers present new mGlu2 receptor modulators

June 11, 2012

Researchers at the CNRS disclose novel inhibitors of tubulin polymerization

June 8, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...